GlassScriptPhysician profile
Alfred J Newman
NPI 1609864867
$4,557.18
in general payments reported to CMS, 2019-2025
33 companies · $225 in 2025
The $225 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $478 · 2020: $477 · 2021: $935 · 2022: $1,093 · 2023: $901 · 2024: $448 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,380 · Education: $194.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,380.09 |
| Education | $193.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dendreon Pharmaceuticals LLC | $880.07 | 2019-2023 | Provenge |
| Astellas Pharma US INC | $671.03 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $449.34 | 2019-2025 | Erleada, Akeega |
| Antares Pharma, INC. | $375.91 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Abbvie INC. | $211.44 | 2019-2023 | |
| Pfizer INC. | $197.30 | 2019-2025 | |
| Myovant Sciences INC. | $182.42 | 2021-2022 | |
| Coloplast Corp | $173.15 | 2019-2023 | Speedicath |
| Kowa Pharmaceuticals America, INC. | $154.88 | 2022-2023 | Seglentis |
| Boston Scientific Corporation | $149.59 | 2019-2021 | |
| Clarus Therapeutics INC. | $124.15 | 2021 | |
| Accord Healthcare, INC. | $91.05 | 2022 | |
| Urovant Sciences INC | $89.53 | 2021-2022 | |
| Myriad Genetic Laboratories, INC. | $87.12 | 2021-2025 | Prolaris |
| Axonics, INC. | $87.08 | 2021-2023 | Axonics |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verity Pharmaceuticals INC. | $84.59 | 2024 | Trelstar |
| Healthtronics Stone Solutions, LLC | $83.48 | 2021 | |
| Endo Pharmaceuticals INC. | $77.22 | 2021-2022 | |
| Abc Home Medical Supply, INC. | $44.52 | 2024-2025 | |
| Tolmar, INC. | $43.29 | 2023-2025 | Eligard, Jatenzo |
| Radius Health, INC. | $34.07 | 2023 | Tymlos |
| Zyla Life Sciences, INC. | $32.70 | 2019 | |
| Sumitomo Pharma America, INC. | $32.67 | 2024 | Orgovyx |
| Allergan, INC. | $28.23 | 2021 | |
| Laborie Medical Technologies Corp. | $26.54 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $25.49 | 2022 | |
| Rochester Medical Corporation | $22.36 | 2021 | |
| Blue Earth Diagnostics | $20.14 | 2021 | |
| Mckesson Patient Care Solutions INC. | $17.38 | 2019 | |
| Hollister Incorporated | $17.19 | 2024 | Vapro Pocket |
| Ambu INC. | $15.62 | 2021 | |
| Ferring Pharmaceuticals INC. | $13.87 | 2019 | |
| Amgen INC. | $13.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alfred Newman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.